Austin, TX, United States of America

Angela M Bardo

This inventor holds 1 USPTO granted patent and 9 published patent applications. Top assignee: The University of Texas System. Active years: 2025.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Angela M Bardo: Innovator in Peptide Capture Technology

Introduction

Angela M Bardo is a notable inventor based in Austin, TX (US). She has made significant contributions to the field of peptide technology, particularly with her innovative patent that addresses solid-phase N-terminal peptide capture and release. Her work is instrumental in advancing research and applications in biochemistry and molecular biology.

Latest Patents

Angela holds a patent for a method titled "SOLID-PHASE N-TERMINAL PEPTIDE CAPTURE AND RELEASE." This patent showcases her expertise and innovative approach to peptide capture, which is crucial for various biochemical applications. She has 1 patent to her name, reflecting her commitment to advancing scientific knowledge and technology.

Career Highlights

Angela is affiliated with The University of Texas System, where she contributes to research and development in her field. Her role at the university allows her to collaborate with other experts and engage in cutting-edge research that pushes the boundaries of current scientific understanding.

Collaborations

Angela has worked alongside notable colleagues such as Cecil J Howard, II and Brendan M Floyd. These collaborations enhance her research efforts and contribute to the innovative environment at The University of Texas System.

Conclusion

Angela M Bardo is a pioneering inventor whose work in peptide technology is making a significant impact in the scientific community. Her contributions through her patent and collaborations highlight her dedication to innovation and research excellence.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…